|
| 37475136 | A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial. | Cancer Res Treat | 2024 |
| 37699162 | Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial. | J Clin Oncol | 2024 |
| 37641819 | Aggressive Local Ablative Radiotherapy Mitigates Progression Risk in Oligometastatic Lung Adenocarcinoma. | Cancer Res Treat | 2024 |
| 36451343 | A randomized Phase 2 study to compare erlotinib with or without bevacizumab in previously untreated patients with advanced non-small cell lung cancer with EGFR mutation. | Cancer | 2023 |
| 37489066 | Safety and tolerability of first-line durvalumab with tremelimumab and chemotherapy in esophageal squamous cell carcinoma. | Cancer Med | 2023 |
| 37712875 | A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors. | Cancer Res Commun | 2023 |
| 37577328 | Prognostic value of baseline and early treatment response of neutrophil-lymphocyte ratio, C-reactive protein, and lactate dehydrogenase in non-small cell lung cancer patients undergoing immunotherapy. | Transl Lung Cancer Res | 2023 |
| 37641544 | First-line nivolumab, paclitaxel, carboplatin, and bevacizumab for advanced non-squamous non-small cell lung cancer: Updated survival analysis of the ONO-4538-52/TASUKI-52 randomized controlled trial. | Cancer Med | 2023 |
| 37104879 | Lazertinib in pretreated EGFR T790M-mutated advanced non-small cell lung cancer: A real-world multicenter study. | Lung Cancer | 2023 |
| 37270588 | CFP1 governs uterine epigenetic landscapes to intervene in progesterone responses for uterine physiology and suppression of endometriosis. | Nat Commun | 2023 |
| 37295609 | Early Circulating Tumor DNA Dynamics and Efficacy of Lorlatinib in Patients With Treatment-Naive, Advanced, ALK-Positive NSCLC. | J Thorac Oncol | 2023 |
| 36650729 | The prognostic value of comprehensive geriatric assessment on the management of older patients with small cell lung cancer. | Korean J Intern Med | 2023 |
| 36397236 | Real World Characteristics and Clinical Outcomes of HER2-Mutant Non-Small Cell Lung Cancer Patients Detected by Next-Generation Sequencing. | Cancer Res Treat | 2023 |
| 36743339 | Outcomes of an Acute Palliative Care Unit at a Comprehensive Cancer Center in Korea. | Palliat Med Rep | 2023 |
| 36672420 | Comparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01). | Cancers (Basel) | 2023 |
| 36456850 | Treatment Patterns, Clinical Outcomes and Health Care Resource Utilisation in Patients with EGFR-mutated Metastatic Non-Small Cell Lung Cancer: A Real-World Study in South Korea. | Drugs Real World Outcomes | 2023 |
| 33940788 | Induction Chemotherapy as a Prognostication Index and Guidance for Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: The Concept of Chemo-Selection (KCSG HN13-01). | Cancer Res Treat | 2022 |
| 35383114 | Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials. | J Immunother Cancer | 2022 |
| 35768997 | Peripubertal requirement of Tsg101 in maintaining the integrity of membranous structures in mouse oocytes. | Cell Prolif | 2022 |
| 35343075 | Disproportional enrichment of FoxP3<sup>+</sup> CD4<sup>+</sup> regulatory T cells shapes a suppressive tumour microenvironment in head and neck squamous cell carcinoma. | Clin Transl Med | 2022 |
| 35533898 | Stachydrine derived from fermented rice prevents diet-induced obesity by regulating adipsin and endoplasmic reticulum homeostasis. | J Nutr Biochem | 2022 |
| 35664056 | Continuous centrifugal microfluidics (CCM) isolates heterogeneous circulating tumor cells via full automation. | Theranostics | 2022 |
| 36544541 | Plasma tumor mutation burden is associated with clinical benefit in patients with non-small cell lung cancer treated with anti-programmed death-1 monotherapy. | Ther Adv Med Oncol | 2022 |
| 36612405 | Examining the Effectiveness of the Discharge Plan Model on the South Korean Patients with Cancer Completed Cancer Treatment and Are Returning to the Community: A Pilot Study. | Int J Environ Res Public Health | 2022 |
| 36539912 | Treatment outcomes and radiotherapy deintensification strategies in human papillomavirus-associated tonsil cancer. | Radiat Oncol | 2022 |
| 36456955 | Role of postoperative radiotherapy in resected adenoid cystic carcinoma of the head and neck. | Radiat Oncol | 2022 |
| 35291660 | Immune Checkpoint Inhibitors in 10 Years: Contribution of Basic Research and Clinical Application in Cancer Immunotherapy. | Immune Netw | 2022 |
| 35251316 | Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models. | Ther Adv Med Oncol | 2022 |
| 35311091 | The Development of AXL Inhibitors in Lung Cancer: Recent Progress and Challenges. | Front Oncol | 2022 |
| 35035536 | Predicting treatment outcomes using <sup>18</sup>F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapy. | Ther Adv Med Oncol | 2022 |
| 35033601 | Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy. | Radiother Oncol | 2022 |
| 34987166 | The importance of enhancer methylation for epigenetic regulation of tumorigenesis in squamous lung cancer. | Exp Mol Med | 2022 |
| 34958928 | A Phase 1/2 Study of Lazertinib 240 mg in Patients With Advanced EGFR T790M-Positive NSCLC After Previous EGFR Tyrosine Kinase Inhibitors. | J Thorac Oncol | 2022 |
| 35323374 | Genomic Landscape of Non-Small Cell Lung Cancer (NSCLC) in East Asia Using Circulating Tumor DNA (ctDNA) in Clinical Practice. | Curr Oncol | 2022 |
| 34789481 | Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice. | Clin Cancer Res | 2022 |
| 34568975 | Efficacy and safety of atezolizumab, in combination with etoposide and carboplatin regimen, in the first-line treatment of extensive-stage small-cell lung cancer: a single-center experience. | Cancer Immunol Immunother | 2022 |
| 32810553 | Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma. | J Hepatol | 2021 |
| 33795826 | Intracranial failure after hippocampal-avoidance prophylactic cranial irradiation in limited-stage small-cell lung cancer patients. | Sci Rep | 2021 |
| 33879814 | Overexpression of PVR and PD-L1 and its association with prognosis in surgically resected squamous cell lung carcinoma. | Sci Rep | 2021 |
| 33683919 | Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451. | J Clin Oncol | 2021 |
| 33783641 | Inhibitor of DNA Binding 2 (ID2): A Novel Marker for Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma. | Ann Surg Oncol | 2021 |
| 33616718 | Overexpression of poliovirus receptor is associated with poor prognosis in head and neck squamous cell carcinoma patients. | J Cancer Res Clin Oncol | 2021 |
| 33777764 | Postoperative Concurrent Chemoradiotherapy <i>Versus</i> Radiotherapy Alone for Advanced Oral Cavity Cancer in the Era of Modern Radiation Techniques. | Front Oncol | 2021 |
| 33723724 | Phase 2 study of TAS-117, an allosteric akt inhibitor in advanced solid tumors harboring phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene homolog gene mutations. | Invest New Drugs | 2021 |
| 33496365 | Different Cre systems induce differential microRNA landscapes and abnormalities in the female reproductive tracts of Dgcr8 conditional knockout mice. | Cell Prolif | 2021 |
| 35003748 | SKI-G-801, an AXL kinase inhibitor, blocks metastasis through inducing anti-tumor immune responses and potentiates anti-PD-1 therapy in mouse cancer models. | Clin Transl Immunology | 2021 |
| 34907028 | Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer. | J Immunother Cancer | 2021 |
| 34903088 | Therapeutic Singing as a Swallowing Intervention in Head and Neck Cancer Patients With Dysphagia. | Integr Cancer Ther | 2021 |
| 34528763 | A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. | Cancer Med | 2021 |
| 34663810 | Dysregulation of T<sub>FH</sub>-B-T<sub>RM</sub> lymphocyte cooperation is associated with unfavorable anti-PD-1 responses in EGFR-mutant lung cancer. | Nat Commun | 2021 |